Country Compliance Lead | Oncology BioTech | Italy

Pubblicato il 28-10-2026 · Major, Lindsey & Africa · Genova

Country Compliance Lead | Clinical-stage oncology | Italy (Remote)

È il candidato/la candidata ideale per questa opportunità? Lo scopra leggendo la panoramica del ruolo qui sotto.

MLA Interim is working with a clinical-stage oncology company on a newly created compliance role in Italy. The business develops targeted therapies, and is preparing for its first product launches in the European market.

The role

This is a sole-contributor position within the Legal and Compliance function, supporting launch readiness and rapid commercial growth in Italy. You will be the go-to compliance adviser for the local business and will shape how the global ethics and compliance programme operates on the ground.

Key responsibilities:

-

- Advising commercial, medical, clinical development, finance and HR teams on day-to-day compliance matters

- Adapting and embedding the global ethics and compliance programme at country level

- Managing transparency reporting and other local disclosure obligations





- Building healthcare and corporate compliance controls that enable successful launch and commercialisation

- Contributing to the development of policies, procedures and wider organisational strategy

What you’ll bring

-

- Established life sciences compliance experience, ideally gained in pharma or biotech

- Exposure to product launches and pre-launch compliance planning

- Working knowledge of local industry codes and transparency requirements

- The confidence to operate independently and partner closely with senior business stakeholders

Why apply

A rare chance to build the local compliance function from the ground up in a well-funded, science-led business at a pivotal point in its growth, with work that directly supports patients with hard-to-treat cancers. xlwpduy

#J-18808-Ljbffr
Per questa posizione sono disponibili opzioni di lavoro a distanza/a casa.
Max. 8 MB. Formati Accettati: PDF, RTF, DOC, DOCX, ODT.